The findings from the new Phase 3 trial, which included more than 32,000 participants, may boost confidence in the vaccine, which was originally developed by…
View More AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company saysThe findings from the new Phase 3 trial, which included more than 32,000 participants, may boost confidence in the vaccine, which was originally developed by…
View More AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says